Literature DB >> 18267265

Treatment of dystonia.

Octavian R Adam1, Joseph Jankovic.   

Abstract

Dystonia varies in severity from simple focal dystonia, such as writer's cramp to life-threatening status dystonicus. Even though the pathophysiology is still elusive, symptomatic treatments may provide marked relief. Botulinum toxin is considered the treatment of choice for most focal and segmental dystonias. Deep brain stimulation of the basal ganglia, particularly the globus pallidus internum, is emerging as an important treatment for refractory, generalized, and segmental forms of dystonia. Gene therapy is also being explored as a possible treatment of inherited dystonias. This article reviews the therapeutic options available for the various types of dystonia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18267265     DOI: 10.1016/S1353-8020(08)70031-2

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

1.  Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.

Authors:  Melanie Hamann; Svenja E Sander; Annette Kreil; Angelika Richter
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

Review 2.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

Review 3.  New clinical and research trends in lower extremity management for ambulatory children with cerebral palsy.

Authors:  Diane L Damiano; Katharine E Alter; Henry Chambers
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

Review 4.  Temporal characteristics of botulinum neurotoxin therapy.

Authors:  Frank J Lebeda; Regina Z Cer; Robert M Stephens; Uma Mudunuri
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 5.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

6.  Prevalence, predictors, and perceived effectiveness of complementary, alternative and integrative medicine in adult-onset primary dystonia.

Authors:  Brandy M Fleming; Emiko L Schwab; Simonne S Nouer; Jim Y Wan; Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2012-05-25       Impact factor: 4.891

7.  An unusual cause of focal hand dystonia due to a retained implant of the distal radius.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Vipul Vijay
Journal:  BMJ Case Rep       Date:  2016-01-08

Review 8.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 9.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

10.  Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing.

Authors:  Frank J Lebeda; Zygmunt F Dembek; Michael Adler
Journal:  J Toxicol       Date:  2011-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.